These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1263839)

  • 1. Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia.
    Davidson MB; Fisher MB; Dabir-Vaziri N; Schaffer M
    Metabolism; 1976 Apr; 25(4):455-64. PubMed ID: 1263839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of growth hormone response to insulin, arginine and haemodialysis in uraemic children.
    Ijaiya K
    Eur J Pediatr; 1979 Jun; 131(3):185-98. PubMed ID: 477677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroid hormone infusion on glucose tolerance and glucose-stimulated insulin secretion in normal and uremic rats.
    Chen SM; Young TK; Ho LT
    Diabetes Res Clin Pract; 1998 Aug; 41(2):85-94. PubMed ID: 9789714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of growth hormone in the glucose intolerance of uremia.
    DeFronzo RA; Tobin J; Boden G; Andres R
    Acta Diabetol Lat; 1979; 16(4):279-86. PubMed ID: 399149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GH, insulin and glucide intolerance in chronic uremia. Changes during hemodialysis treatment and after renal transplantation].
    Orsoni G; Capelli M; Scolari MP; Vangelista A; Bonomini V
    Minerva Nefrol; 1980; 27(4):655-8. PubMed ID: 7019773
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of uremia and hemodialysis on the turnover and metabolic effects of glucagon.
    Sherwin RS; Bastl C; Finkelstein FO; Fisher M; Black H; Hendler R; Felig P
    J Clin Invest; 1976 Mar; 57(3):722-31. PubMed ID: 1249205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response to intravenous glucose of patients on maintenance hemodialysis: effects of dialysis.
    Ferrannini E; Pilo A; Tuoni M
    Metabolism; 1979 Feb; 28(2):125-36. PubMed ID: 763147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.
    Schmitz O; Orskov L; Lund S; Møller N; Christiansen JS; Orskov H
    J Pediatr Endocrinol; 1993; 6(1):53-9. PubMed ID: 8374690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dialysis treatment on glucose metabolism in uremic patients.
    Kaneda H; Mimura N
    Tohoku J Exp Med; 1977 May; 122(1):35-42. PubMed ID: 918954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin, branched-chain amino acids, and growth failure in uremia.
    Mak RH
    Pediatr Nephrol; 1998 Oct; 12(8):637-42. PubMed ID: 9811385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion and growth failure in uremia.
    Mak RH
    Pediatr Res; 1995 Sep; 38(3):379-83. PubMed ID: 7494663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbohydrate metabolism in uremia.
    Mak RH
    Pediatr Nephrol; 1989 Apr; 3(2):201-8. PubMed ID: 2701869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads.
    Allegra V; Mengozzi G; Martimbianco L; Vasile A
    Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients.
    Mak RH
    Kidney Int; 1992 Apr; 41(4):1049-54. PubMed ID: 1513086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose, insulin and glucagon response to intravenous glucose load in patients on chronic hemodialysis.
    Shasha SM; Nusem D; Kanter Y; Weiner F
    Isr J Med Sci; 1988 Jan; 24(1):15-9. PubMed ID: 3279011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet insulin content and release are increased in male mice with elevated endogenous GH and IGF-I, without evidence of systemic insulin resistance or alterations in β-cell mass.
    Cordoba-Chacon J; Majumdar N; Pokala NK; Gahete MD; Kineman RD
    Growth Horm IGF Res; 2015 Aug; 25(4):189-95. PubMed ID: 25936582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat.
    Harel Z; Tannenbaum GS
    Pediatr Res; 1995 Nov; 38(5):747-53. PubMed ID: 8552444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.
    Schmitz O; Alberti KG; Christensen NJ; Hasling C; Hjøllund E; Beck-Nielsen H; Orskov H
    Metabolism; 1985 May; 34(5):465-73. PubMed ID: 3887103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.